Cargando…

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

Detalles Bibliográficos
Autor principal:	Park, Jihye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831776/ https://www.ncbi.nlm.nih.gov/pubmed/35135074 http://dx.doi.org/10.5217/ir.2021.00170

Ejemplares similares

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
por: Park, Jihye
Publicado: (2023)

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
por: Poylin, Vitaliy Y., et al.
Publicado: (2022)

Choosing a Second Biologic Agent for Inflammatory Bowel Disease Patients—Cost Considerations and Clinical Outcomes
por: Clarke, Kofi
Publicado: (2020)

Oral Health in Patients with Inflammatory Bowel Diseases Qualified for Biologic Treatment
por: Nijakowski, Kacper
Publicado: (2022)

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
por: García, María José, et al.
Publicado: (2021)

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
por: Eun, Chang Soo
Publicado: (2017)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease
por: Tran-Minh, My-Linh, et al.
Publicado: (2017)

Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
por: Krusiński, Adam, et al.
Publicado: (2021)

Markers of Perioperative Bowel Complications in Colorectal Surgery Patients
por: Hyšpler, Radomír, et al.
Publicado: (2015)

The Mental Health State of Quiescent Inflammatory Bowel Disease Patients
por: Park, Sung Chul, et al.
Publicado: (2016)

Perioperative management of patients with liver cancer complicated with sarcopenia
por: Xing, Jiali, et al.
Publicado: (2022)

Biologic agents in inflammatory bowel disease – quality of internet website information
por: Rofaiel, Rymon, et al.
Publicado: (2018)

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries
por: Baek, Ji Eun, et al.
Publicado: (2023)

Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support
por: Stoner, Patrick L., et al.
Publicado: (2018)

Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
por: Parra, Rogerio Serafim, et al.
Publicado: (2023)

The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective
por: Ali, Raja Affendi Raja
Publicado: (2015)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Biomarkers and Cellular Biology in Perioperative Medicine
por: Larmann, Jan, et al.
Publicado: (2022)

Incidence and Prevalence of Inflammatory Bowel Disease across Asia
por: Park, Jihye, et al.
Publicado: (2021)

Lung injury as an extra-intestinal manifestation of inflammatory bowel disease
por: Park, Kyung Sik
Publicado: (2016)

Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Does infliximab increase complications after surgery for inflammatory bowel disease?
por: Holubar, Stefan D, et al.
Publicado: (2009)

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
por: Park, Yong Eun
Publicado: (2022)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
por: Kim, So Yeon
Publicado: (2020)

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
por: Kang, Eun Ae, et al.
Publicado: (2022)

Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?
por: Park, Suhyun, et al.
Publicado: (2022)

Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases
por: Ahn, Soo Min, et al.
Publicado: (2023)

Does Radiation Exposure from Abdominal Computed Tomography Increase Cancer Risk in Patients with Inflammatory Bowel Disease and Behçet Disease?
por: Lim, Yun Jeong
Publicado: (2014)

Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
por: Lee, Jung Won
Publicado: (2017)

Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic Cycling
por: Alizadeh, Madeline, et al.
Publicado: (2023)

Irritable Bowel Syndrome or Psychiatric Disorders: Which Comes First?
por: Lee, Hong Sub
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0hvvt02rl1tm95kihtcdmn7bnl